Stratos Wealth Partners, Ltd. Adma Biologics, Inc. Transaction History

Stratos Wealth Partners, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	BUY	$2.47 - $3.88 $86 - $135	35 Added 0.09%	40,035 $0
Q1 2022 Apr 26, 2022	BUY	$1.28 - $1.83 $51,200 - $73,200	40,000 New	40,000 $73,000
Q4 2021 Jan 14, 2022	SELL	$1.09 - $1.66 $21,800 - $33,200	-20,000 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$1.67 - $2.95 $33,400 - $59,000	20,000 New	20,000 $35,000
Q4 2020 Jan 29, 2021	SELL	$1.8 - $2.56 $36,000 - $51,200	-20,000 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$1.5 - $4.59 $30,000 - $91,800	20,000 New	20,000 $58,000

326

190M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.31B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.